(NaturalNews)
(Natural News) Since 2016, pharmaceutical giant AbbVie has generated more than $114 billion in revenue from the sale of its anti-inflammatory drug Humira. That same year, Humira was supposed to go off-patent and become generic – meaning it would have cost a whole lot less for consumers – but because of patent manipulation, AbbVie has been … [Read More…] |
Related posts:
Diaspora Ministry Unveils System for Tracking Online Anti-Semitism
Britain and Saudi Arabia: Partners in High Crimes
Biden Administration Proposes Dramatic Change to Asylum System Amid Border Crisis
Getting In On Canada’s $30 Billion Marijuana Boom
PFLP’s Leila Khaled Speaks at Resistance Festival in Greece
UAE Accused Of Funding Coup Attempt On Turkey, To The Tune Of $3 Billion